Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsCurrent Helicobacter pylori treatment in 2014A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapyOptimal treatment strategy for Helicobacter pylori: era of antibiotic resistance."Concomitant" or "sequential" eradication of Helicobacter pylori: which regimen comes first?First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelinesTreatment of Helicobacter pylori infection: Past, present and futureSeven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy.Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication: A prospective single-center study from ChinaComparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication.Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trialNonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.Sequential versus concomitant therapy for eradication of Helicobacter Pylori in patients with perforated duodenal ulcer: A randomized trialOptimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies.Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance.Treatment of Helicobacter pylori infection 2014.Review: clinical management of Helicobacter pylori infection in China.Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.Helicobacter pylori treatment: Still a work in progress.Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.Role of concomitant therapy for Helicobacter pylori eradication: A technical note.Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance.Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea.Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection
P2860
Q26777623-268DEC58-10DB-4093-BCD1-252CED2E2F6AQ26778023-E07CCBBD-8546-49C4-BDEC-DB2F3EB84254Q27000209-32EB08B3-45BF-45BE-A101-B1FCF1C2166FQ27687842-FCD3D281-7CDB-4825-A524-30044DBC12E6Q28296156-90D7DBC3-2A8F-4FC5-8B2A-FBC0E6AAD076Q33626779-88CA27E2-472E-49E1-BF60-A8D4B47560EEQ33813453-C037640A-55AD-43F8-9F2A-534ACF49E0E9Q33822948-8A9BCD07-C4BE-4512-9B11-6C3FB3089146Q34508830-6514C86F-8F92-4DF4-BEA8-95870E441AF5Q35674499-3EE226E8-024B-47BF-B09B-5F9BD04EFF1DQ35940597-13845461-8B13-4496-9749-604910BD0E80Q36168093-A915215F-778B-4FEE-9B91-E12185E17D45Q36448524-2863E5C4-90E9-4872-A283-F34534DEAAEFQ36614237-39E4277C-A193-4C44-B6F1-473E803B5C1AQ37012409-9FF493DB-5C2B-4914-8027-DC79D0BC18CAQ37189556-8A01F056-5B3A-4938-B0C4-9D973C2BB0E1Q37533456-6BCBE453-A7E2-4C7C-877C-FF812599606AQ37656247-51E8A309-976D-4A5B-AA51-FD412410F98AQ38191566-DD52693E-19E4-4477-83D8-148EF9FF89C8Q38238745-5E88541A-3B6E-4A81-9998-B1CFF86747E5Q38240845-0D59F3E3-4CB7-4EDC-92E4-A77541F4DA52Q38244257-17410D59-A1B9-4A3D-BEB9-6025CCF7BAAEQ38266432-9BAB3A8B-3DD2-4EC8-BCB2-3CB35DC86218Q38418244-EEA319C9-A0B6-4BB1-9E64-6A792FF983D7Q38496942-DD096AB7-4D78-4BBC-AE75-8584941284BCQ38578674-E1A73B8D-5122-4F84-AC03-193138FF7B60Q38613590-D2612E8E-A5E4-493C-B1B9-B318B5F66794Q38876344-7435006D-BF9F-41E0-8DF5-6C26F7EA349FQ39135143-DE6DD0E5-DAAD-4A63-86EA-F6A55F84CE3EQ39196966-37878ADE-0C81-4552-A8D0-4E91E6071ACEQ40482860-8BC39C58-6264-43BA-80A6-B9B26B885088Q40582588-1AE4A332-7B17-44F4-9E18-FBF553AA9FE5Q40702356-D4AA8FA7-C8A8-4AC8-A8C6-74EC7E9A2549Q40967062-4E2D1FA5-6A6E-4C09-99E2-77088355F200Q41143818-28C133D9-6737-41D5-A800-3CA166C92D7DQ41224420-4A47A78F-055E-40FD-9275-1836E35AA156Q41339710-A659722D-75A5-4136-BE26-92F72B829BBCQ41511318-EEA65BF1-8216-45EC-982D-603B8A2275CAQ41680509-3DD07182-CFEE-45B3-906F-71DFB3A6665EQ41682366-4EE219ED-7801-41B6-A2E6-D9E2A490BEC8
P2860
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Randomised clinical trial comp ...... in routine clinical practice.
@en
Randomised clinical trial comp ...... in routine clinical practice.
@nl
type
label
Randomised clinical trial comp ...... in routine clinical practice.
@en
Randomised clinical trial comp ...... in routine clinical practice.
@nl
prefLabel
Randomised clinical trial comp ...... in routine clinical practice.
@en
Randomised clinical trial comp ...... in routine clinical practice.
@nl
P2093
P2860
P50
P1433
P1476
Randomised clinical trial comp ...... n in routine clinical practice
@en
P2093
Angeles Perez-Aisa
Felipe Bory
Javier Molina-Infante
Javier P Gisbert
Jesús Barrio
Julio Ducons
Manuel Castro
Miguel Montoro
Montserrat Forné
Participant Centres
P2860
P304
P356
10.1136/GUTJNL-2013-304820
P407
P577
2013-05-11T00:00:00Z